Details and registration can be found here: https://app.medall.org/event-listings/6th-annual-oxford-surgical-innovation-conference
The article describes some of the incredible uses of silk and the work we’re doing to bring a new standard of treatment for patient’s who have suffered catastrophic nerve injuries. Check out the article on the University of Oxford website here: https://oxford.shorthandstories.com/spiders-surgery-and-sustainable-silk/index.html
The finalists for the “Value Award” are selected by large strategics, entrepreneurs and investors to showcase the companies bringing a great value proposition with their technology. Following the great response from the recent presentation at the American Society of Plastic Surgeons (ASPS) conference, this is further recognition of the value of our silk repair technology and the huge impact it will have on patients lives. Read the full press release here: https://medtechinnovator.org/medtech-innovator-announces-finalists-of-inaugural-2023-mid-stage-competition/. We’re looking forward to the competition at the MedTech Strategist Innovation Summit in San Francisco.
Newrotex wins a prize in Austin, Texas at the American Society of Plastic Surgeons (ASPS) 92nd Annual Plastic Surgery The Meeting! Newrotex was selected by the ASPS Plastic Surgery Accelerator powered by MedTech Innovator, and featured as one of 5 best-in-class startups: Newrotex Ltd, ImmersiveTouch, Fingy3D, 4th Dimension EMR, Inc and Cellulora. The culmination of the program was a live competition at the plastic surgery annual meeting where the audience voted Fingy3D for Best Overall Winner and Newrotex Ltd for Runner-Up. We were delighted with all the positive feedback from plastic surgeons and strategic companies on our technology and the clear need for patients. We’re looking forward to all of the exciting new collaborative opportunities going forwards.
Dr Woods said, “The MedTech Innovator Acceleartor programme has been hugely valuable to Newrotex. Working with so many expert entrepreneurs, clinical experts and large strategics to refine our value proposition, strategy and market value has been invaluable. As well as making friends with so many incredible entrepreneurs! It was a great honour for Newrotex to have been selected as one of the top 5 companies from the MedTech Innovator 2023 cohort – from an initial 1,150 companies across the world who applied this year – it really shows the value of what we’re trying to achieve for patients. Congratulations to winners StrokeDx and to the other incredible companies who were included in the Finals IFPx, Fingy3D, and Neurava Inc.
Take a listen here! https://soundcloud.com/devicetalks/hear-the-last-10-start-ups-standing-in-medtech-innovators-pitch-competitions
Newrotex are delighted to announce that we have been selected to join the prestigious MedTech Innovator programme. 61 companies were selected from over 1,150 applicants worldwide and the team will kick off in San Francisco next week. CEO Alex Woods “We’re incredibly proud to have been selected for the MedTech Innovator Accelerator programme including the American Society of Plastic Surgeons (ASPS) cohort. It recognises how our regenerative silk technology can help to address the large unmet need for patients to have a robust and effective treatment for nerve injuries”. Read more
Newrotex have been awarded an “Outstanding Pitch” award from the Medical Technology Enterprise Consortium (MTEC) following on from the recent MedTech Innovator Road Tour Pitch Event. MTEC are a consortium focuses on the development of medical solutions that protect, treat, and optimize the health and performance of U.S. military personnel and civilians. Newrotex are delighted to receive this recognition of the huge value our technology can offer to early treatment for injured military personnel and CCO Andrew Elphick will be travelling to Richmond, VA to receive the award at MTEC’s 8th Annual Membership Meeting.
Newrotex are delighted to announce that we have successfully received an i4i FAST (Funding at the Speed of Translation) Award form the National Institute for Health and Care Research (NIHR). The award, lead by Chief Science Officer Dr Robyn Plowright, will help Newrotex to develop QMS systems to meet regulatory requirements to bring our technology closer to patients.
Newrotex were pleased to welcome the Sunday Mirror to our office and lab space and to discuss the important work we are doing to bringing our exciting silk technology closer to patients. The full article is found here: EXCLUSIVE: Spider’s silk could be used to repair human nerve damage in ‘exciting’ new treatment
